ReachMD

Dr. Lynne M. Mofenson is an infectious disease specialist and board-certified pediatrician. She is currently chief, pediatric, adolescent and maternal AIDS branch at the National Institute of Child Health and Human Development, National Institutes of Health, where she has worked since 1989 and been chief since 2000. Dr. Mofenson is responsible for program planning and the development and scientific direction of research studies and clinical trials in domestic and international pediatric, adolescent and maternal HIV infection, disease and AIDS.

Dr. Mofenson received her medical degree from Albert Einstein College of Medicine (Alpha Omega Alpha) in 1977, followed by a pediatric residency at Boston Children's Hospital, and a pediatric Chief Residency and joint adult/pediatric infectious disease fellowship at the University of Massachusetts Medical School.

Dr. Mofenson has published and lectured extensively on issues related to perinatal HIV transmission and prevention and on treatment of pediatric HIV infection, and is involved in clinical trials of HIV treatment in children and women and prevention mother-to-child HIV transmission in the United States and internationally.  Dr. Mofenson is executive secretary of the U.S. Public Health Task Force that develops national recommendations on use of antiretroviral drugs in HIV-infected pregnant women for reducing perinatal HIV transmission and treatment of maternal HIV disease and also executive secretary for the Pediatric Antiretroviral Guidelines Working Group that develops guidelines for treatment of HIV infection in children.  She is a consultant to international organizations such as the World Health Organization on policies related to antiretroviral treatment of HIV-infected children and women and on prevention of mother-to-child HIV transmission.